Baseline characteristics of responders and nonresponders...

European Journal of Cancer 2017 / 02 Vol. 72

Baseline characteristics of responders and nonresponders from the phase 3 study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)

Reuter, C., Yu, X., Baig, M., Dutcus, C.E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
72
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(17)30452-5
Date:
February, 2017
File:
PDF, 60 KB
english, 2017
Conversion to is in progress
Conversion to is failed